Literature DB >> 20869852

Emergence of carbapenem resistance due to porin loss in an extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy.

D P Webster, T Gaulton, N Woodford, R Pike, J Turton, C Perry, I C J W Bowler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20869852     DOI: 10.1016/j.ijantimicag.2010.08.003

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  5 in total

1.  Colistin resistance mechanisms in Klebsiella pneumoniae strains from Taiwan.

Authors:  Yi-Hsiang Cheng; Tzu-Lung Lin; Yi-Jiun Pan; Yu-Ping Wang; Yi-Tsung Lin; Jin-Town Wang
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

Review 2.  Carbapenems: past, present, and future.

Authors:  Krisztina M Papp-Wallace; Andrea Endimiani; Magdalena A Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

3.  Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant.

Authors:  Aggeliki Poulou; Evangelia Voulgari; Georgia Vrioni; Vasiliki Koumaki; Grigorios Xidopoulos; Vasiliki Chatzipantazi; Fani Markou; Athanassios Tsakris
Journal:  J Clin Microbiol       Date:  2013-07-12       Impact factor: 5.948

4.  Role of the Outer Membrane and Porins in Susceptibility of β-Lactamase-Producing Enterobacteriaceae to Ceftazidime-Avibactam.

Authors:  Jean-Marie Pagès; Sabine Peslier; Thomas A Keating; Jean-Philippe Lavigne; Wright W Nichols
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

5.  Carbapenemase genes among multidrug resistant gram negative clinical isolates from a tertiary hospital in Mwanza, Tanzania.

Authors:  Martha F Mushi; Stephen E Mshana; Can Imirzalioglu; Freddie Bwanga
Journal:  Biomed Res Int       Date:  2014-02-24       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.